Last reviewed · How we verify
NCT05713968
Swallowing Evaluation by HRIM in Patients With Cervical Spondylosis
trial testing patients with EAT-10 higher than 3 or frailty questionnaire higher than 2 examined by HRIM in Upper Esophageal Sphincter Relaxing Pressure in 50 participants. Not yet recruiting.
31 December 2027
Quick facts
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 27 January 2023 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2029 |
Drugs / interventions tested
- patients with EAT-10 higher than 3 or frailty questionnaire higher than 2 examined by HRIM
- patients with EAT-10 lower than 3 or frailty questionnaire lower than 2
Conditions studied
- Upper Esophageal Sphincter Relaxing Pressure — all drugs for Upper Esophageal Sphincter Relaxing Pressure →
Sponsor
National Taiwan University Hospital
Who can join
20 and older, any sex, with Upper Esophageal Sphincter Relaxing Pressure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
patients with cervical spondylolysis may have swallowing or eating difficulty. In this study, we will use high resolution impedance manometry to evaluate these patients' detailed swallowing mechanisms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05713968
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other National Taiwan University Hospital trials
Trials by the same sponsor.
- NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
- NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
- NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
- NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05713968 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
- Last refreshed: 6 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05713968.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing